Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-01

Clinical Trial Update: MediBeacon® Transdermal GFR System for the Evaluation of Kidney Function in Adults With Heart Failure [NA]

View source ↗

Summary

MediBeacon reports a clinical trial evaluating its transdermal GFR system to assess kidney function in adults with heart failure. The study is currently not yet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MediBeacon Transdermal GFR System

Snippet

Sponsor: MediBeacon | Conditions: Glomerular Filtration Rate, Heart Failure | NA | Status: NOT_YET_RECRUITING